Impact of a G-CSF Policy to Reduce Low-Value Care on Guideline Adherence and Mortality.

Orji, Chinelo C; Brown, Carolyn M; Hoverman, J Russell; Richards, Kristin M; Garey, Jody; He, Bo

Orji, Chinelo C; Brown, Carolyn M; Hoverman, J Russell; Richards, Kristin M; Garey, Jody; He, Bo.

Afiliación

Orji CC; Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX.
Brown CM; Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX.
Hoverman JR; Texas Oncology, Austin, TX.
Richards KM; Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX.
Garey J; McKesson Specialty Health, The Woodlands, TX.
He B; McKesson Specialty Health, The Woodlands, TX.

JCO Oncol Pract ; 17(11): e1830-e1836, 2021 11.

Article en En | MEDLINE | ID: mdl-33852326

Asunto(s)

Factor Estimulante de Colonias de Granulocitos; Neoplasias; Factor Estimulante de Colonias de Granulocitos/uso terapéutico; Adhesión a Directriz; Humanos; Atención de Bajo Valor; Políticas; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor Estimulante de Colonias de Granulocitos / Neoplasias Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Oncol Pract Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google